Compare INOD & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INOD | STVN |
|---|---|---|
| Founded | 1988 | 1949 |
| Country | United States | Italy |
| Employees | 3000 | N/A |
| Industry | EDP Services | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | 1996 | 2021 |
| Metric | INOD | STVN |
|---|---|---|
| Price | $101.18 | $17.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $100.00 | $25.67 |
| AVG Volume (30 Days) | ★ 1.8M | 294.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ 3.37 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $86,775,000.00 | N/A |
| Revenue This Year | $38.42 | $9.67 |
| Revenue Next Year | $27.03 | $9.99 |
| P/E Ratio | $247.90 | ★ $27.15 |
| Revenue Growth | ★ 9.84 | N/A |
| 52 Week Low | $34.23 | $12.89 |
| 52 Week High | $125.14 | $28.00 |
| Indicator | INOD | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.17 | 39.65 |
| Support Level | $40.64 | $13.58 |
| Resistance Level | $119.96 | $17.19 |
| Average True Range (ATR) | 11.34 | 0.82 |
| MACD | -2.41 | -0.25 |
| Stochastic Oscillator | 36.87 | 12.66 |
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.